1. Home
  2. NVG vs CNTA Comparison

NVG vs CNTA Comparison

Compare NVG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVG
  • CNTA
  • Stock Information
  • Founded
  • NVG 1999
  • CNTA 2020
  • Country
  • NVG United States
  • CNTA United Kingdom
  • Employees
  • NVG N/A
  • CNTA N/A
  • Industry
  • NVG Investment Managers
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVG Finance
  • CNTA Health Care
  • Exchange
  • NVG Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • NVG 2.7B
  • CNTA 2.3B
  • IPO Year
  • NVG N/A
  • CNTA 2021
  • Fundamental
  • Price
  • NVG $12.34
  • CNTA $16.51
  • Analyst Decision
  • NVG
  • CNTA Strong Buy
  • Analyst Count
  • NVG 0
  • CNTA 7
  • Target Price
  • NVG N/A
  • CNTA $23.71
  • AVG Volume (30 Days)
  • NVG 568.8K
  • CNTA 704.8K
  • Earning Date
  • NVG 01-01-0001
  • CNTA 11-12-2024
  • Dividend Yield
  • NVG 4.65%
  • CNTA N/A
  • EPS Growth
  • NVG N/A
  • CNTA N/A
  • EPS
  • NVG N/A
  • CNTA N/A
  • Revenue
  • NVG N/A
  • CNTA $6,853,000.00
  • Revenue This Year
  • NVG N/A
  • CNTA N/A
  • Revenue Next Year
  • NVG N/A
  • CNTA N/A
  • P/E Ratio
  • NVG N/A
  • CNTA N/A
  • Revenue Growth
  • NVG N/A
  • CNTA N/A
  • 52 Week Low
  • NVG $9.68
  • CNTA $6.65
  • 52 Week High
  • NVG $12.21
  • CNTA $18.97
  • Technical
  • Relative Strength Index (RSI)
  • NVG 28.58
  • CNTA 46.55
  • Support Level
  • NVG $13.08
  • CNTA $15.88
  • Resistance Level
  • NVG $13.27
  • CNTA $18.12
  • Average True Range (ATR)
  • NVG 0.17
  • CNTA 1.01
  • MACD
  • NVG -0.09
  • CNTA -0.14
  • Stochastic Oscillator
  • NVG 2.36
  • CNTA 20.39

About NVG Nuveen AMT-Free Municipal Credit Income Fund

Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Share on Social Networks: